您现在位置: -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告
讯:
Research Report on Chinese Statins Market Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd Published: July 2006 Format: Hardcopy and Adobe PDF Price: US$2,300 Contact: Mr. Bian chenghua Ms. Wu huifang Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68012929-2008 E-mail: bianch@healthoo.com wuhf@healthoo.com //m.limatoxi.com Directory 1 Market scale and growth trend of cardiovascular drugs 2 Overview about lipids regulating drugs marekt 2.1 Academic market capacity 2.2 Overview about hospital market and retail market 3 Analysis about hospital market 3.1 Growth trend of lipids regulating drugs in the past few years 3.2 Market shares of different categories 3.3 Sales rank of breeds of lipids regulating drugs 3.4 Sales analysis in key cities 3.5 Sales analysis of Statin drugs 3.5.1 Simvastatin(Zocor) 3.5.2 Lovastatin(Mevacor) 3.5.3 Pravastatin 3.5.4 Fluvastatin(Lescol) 3.5.5 Atorvastatin 3.5.6 Rosuvastatin 3.5.7 Compound preparation of Statins ezetimibe/Simvastatin (Vytorin) Torcetrapib/Atorvastatin MK-0524A/Zocor Statins+cholalic acid chelating agent Other compound preparation of Statins 3.6 Analysis about manufacturing enterprises 3.6.1 Market share of procucts made by domestic, foreign, joint venture enterprises 3.6.2 Top 15 manufacturing enterprising last year 4 Analysis about retail market 4.1 Market shares of different categories 4.2 Sales rank of breeds of lipids regulating drugs 4.3 Sales shares of enterprises which produce TCM for lipids regulating 4.4 Enterprise list ranked by sales value 4.5 Top 15 enterpsies ranked by sales value in different cities 4.5.1 Beijing 4.5.2 Shanghai 4.5.3 Guangzhou 4.5.4 Wuhan 4.5.5 Shenyang 4.5.6 Chengdu 4.5.7 Hangzhou 4.5.8 Shenzhen 4.5.9 Shijiazhuang 4.5.10 Zhengzhou
|